BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakano M, Nakajima M. Current knowledge of microRNA-mediated regulation of drug metabolism in humans. Expert Opin Drug Metab Toxicol 2018;14:493-504. [PMID: 29718737 DOI: 10.1080/17425255.2018.1472237] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhao C, Zhang Y, Popel AS. Mechanistic Computational Models of MicroRNA-Mediated Signaling Networks in Human Diseases. Int J Mol Sci 2019;20:E421. [PMID: 30669429 DOI: 10.3390/ijms20020421] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
2 Smutny T, Hyrsova L, Braeuning A, Ingelman-Sundberg M, Pavek P. Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism. Arch Toxicol 2021;95:11-25. [PMID: 33164107 DOI: 10.1007/s00204-020-02916-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci 2020;16:2628-47. [PMID: 32792861 DOI: 10.7150/ijbs.47203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
4 Negishi M, Kobayashi K, Sakuma T, Sueyoshi T. Nuclear receptor phosphorylation in xenobiotic signal transduction. J Biol Chem 2020;295:15210-25. [PMID: 32788213 DOI: 10.1074/jbc.REV120.007933] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
5 Rocic P, Schwartzman ML. 20-HETE in the regulation of vascular and cardiac function. Pharmacol Ther 2018;192:74-87. [PMID: 30048707 DOI: 10.1016/j.pharmthera.2018.07.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
6 Cavalcante P, Mantegazza R, Bernasconi P. Pharmacogenetic and pharmaco-miR biomarkers for tailoring and monitoring myasthenia gravis treatments. Expert Review of Precision Medicine and Drug Development 2020;5:317-29. [DOI: 10.1080/23808993.2020.1804865] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li D, Wu L, Knox B, Chen S, Tolleson WH, Liu F, Yu D, Guo L, Tong W, Ning B. Long noncoding RNA LINC00844-mediated molecular network regulates expression of drug metabolizing enzymes and nuclear receptors in human liver cells. Arch Toxicol 2020;94:1637-53. [PMID: 32222775 DOI: 10.1007/s00204-020-02706-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kugler N, Klein K, Zanger UM. MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation. Biochem Pharmacol 2020;171:113725. [PMID: 31758923 DOI: 10.1016/j.bcp.2019.113725] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Lin YS, Thummel KE, Thompson BD, Totah RA, Cho CW. Sources of Interindividual Variability. Methods Mol Biol 2021;2342:481-550. [PMID: 34272705 DOI: 10.1007/978-1-0716-1554-6_17] [Reference Citation Analysis]
10 Li D, Tolleson WH, Yu D, Chen S, Guo L, Xiao W, Tong W, Ning B. MicroRNA-Dependent Gene Regulation of the Human Cytochrome P450. Pharmacoepigenetics. Elsevier; 2019. pp. 129-38. [DOI: 10.1016/b978-0-12-813939-4.00004-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Yi W, Tu MJ, Liu Z, Zhang C, Batra N, Yu AX, Yu AM. Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. Acta Pharm Sin B 2020;10:159-70. [PMID: 31993313 DOI: 10.1016/j.apsb.2019.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
12 Nakano M, Ondo K, Takemoto S, Fukami T, Nakajima M. Methylation of adenosine at the N6 position post-transcriptionally regulates hepatic P450s expression. Biochemical Pharmacology 2020;171:113697. [DOI: 10.1016/j.bcp.2019.113697] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
13 Ning B, Yu D, Yu AM. Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics. Biochem Pharmacol 2019;169:113638. [PMID: 31518552 DOI: 10.1016/j.bcp.2019.113638] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
14 Nuzziello N, Ciaccia L, Liguori M. Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World. Cells 2019;9:E75. [PMID: 31892254 DOI: 10.3390/cells9010075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
15 Li D, Tolleson WH, Yu D, Chen S, Guo L, Xiao W, Tong W, Ning B. Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2019;37:180-214. [PMID: 31305208 DOI: 10.1080/10590501.2019.1639481] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
16 Sun J, Yang J, Chi J, Ding X, Lv N. Identification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction. Hum Genomics 2018;12:52. [PMID: 30514363 DOI: 10.1186/s40246-018-0184-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, Yu AM, Zuo Z, Bi H. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B 2019;9:1113-44. [PMID: 31867160 DOI: 10.1016/j.apsb.2019.10.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
18 Rytkin EI, Mirzaev KB, Bure IV, Sychev DA. Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors. Terapevticheskii arkhiv 2019;91:115-7. [DOI: 10.26442/00403660.2019.08.000389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Smutny T, Dusek J, Hyrsova L, Nekvindova J, Horvatova A, Micuda S, Gerbal-Chaloin S, Pavek P. The 3'-untranslated region contributes to the pregnane X receptor (PXR) expression down-regulation by PXR ligands and up-regulation by glucocorticoids. Acta Pharm Sin B 2020;10:136-52. [PMID: 31998607 DOI: 10.1016/j.apsb.2019.09.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
20 Hu DG, Hulin JU, Nair PC, Haines AZ, McKinnon RA, Mackenzie PI, Meech R. The UGTome: The expanding diversity of UDP glycosyltransferases and its impact on small molecule metabolism. Pharmacol Ther 2019;204:107414. [PMID: 31647974 DOI: 10.1016/j.pharmthera.2019.107414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Liu W, Nakano M, Nakanishi T, Nakajima M, Tamai I. Post-transcriptional regulation of OATP2B1 transporter by a microRNA, miR-24. Drug Metabolism and Pharmacokinetics 2020;35:515-21. [DOI: 10.1016/j.dmpk.2020.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Krkoška M, Nekvindová J, Nevědělová K, Zubáňová V, Radová L, Vondráček J, Herůdková J, Slabý O, Kiss I, Bohovicová L, Fabian P, Tylichová Z, Kala Z, Kysela P, Ostřížková L, Palička V, Hyršlová Vaculová A. Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma. Pharmacol Rep 2021. [PMID: 34780054 DOI: 10.1007/s43440-021-00338-9] [Reference Citation Analysis]
23 Nakano M, Iwakami C, Fukami T, Nakajima M. Identification of miRNAs that regulate human CYP2B6 expression. Drug Metab Pharmacokinet 2021;38:100388. [PMID: 33872945 DOI: 10.1016/j.dmpk.2021.100388] [Reference Citation Analysis]
24 Takemoto S, Nakano M, Nozaki K, Fukami T, Nakajima M. Adenosine deaminases acting on RNA modulate the expression of the human pregnane X receptor. Drug Metab Pharmacokinet 2021;37:100367. [PMID: 33515843 DOI: 10.1016/j.dmpk.2020.11.002] [Reference Citation Analysis]
25 Gambari R, Gasparello J, Fabbri E, Borgatti M, Tamanini A, Finotti A. Peptide Nucleic Acids for MicroRNA Targeting. Methods Mol Biol 2020;2105:199-215. [PMID: 32088872 DOI: 10.1007/978-1-0716-0243-0_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Li D, Knox B, Chen S, Wu L, Tolleson WH, Liu Z, Yu D, Guo L, Tong W, Ning B. MicroRNAs hsa-miR-495-3p and hsa-miR-486-5p suppress basal and rifampicin-induced expression of human sulfotransferase 2A1 (SULT2A1) by facilitating mRNA degradation. Biochem Pharmacol 2019;169:113617. [PMID: 31445882 DOI: 10.1016/j.bcp.2019.08.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Cavalcante P, Mizrachi T, Barzago C, Scandiffio L, Bortone F, Bonanno S, Frangiamore R, Mantegazza R, Bernasconi P, Brenner T, Vaknin-Dembinsky A, Antozzi C. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine. Pharmacol Res 2019;148:104388. [PMID: 31401213 DOI: 10.1016/j.phrs.2019.104388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
28 Li X, Tian Y, Tu MJ, Ho PY, Batra N, Yu AM. Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression. Acta Pharm Sin B 2019;9:639-47. [PMID: 31193825 DOI: 10.1016/j.apsb.2018.12.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
29 Luo J, Xie M, Hou Y, Ma W, Jin Y, Chen J, Li C, Zhao K, Chen N, Xu L, Ji Y, Zhang Q, Zheng Y, Yu D. A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease. Biochem Pharmacol 2021;188:114582. [PMID: 33895159 DOI: 10.1016/j.bcp.2021.114582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]